Dr. Aida Azar is an Associate Professor of Epidemiology at the College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU). She joined MBRU since its inception in 2016. In her current position, she is responsible for developing the Epidemiology, Biostatistics and Research Curricula for the entire MBBS program. This is integrated with the evidence-based approach. She is part of the MBRU vision of delivering high-quality education that places the student at the center of the learning experience to become a lifelong learner.

During Dr. Azar’s scientific career, she was involved in various disciplines. She taught medical, nursing and health sciences students in various universities. She was part of a number of collaborative groups on writing Cardiovascular Guidelines. She initiated the first cardiovascular guideline using evidence-based medicine, in collaboration with the Cochrane Centre, The Netherlands (CBO/WHO/MOH). She was involved in various cardiovascular clinical trials. She was engaged in research that interacted with the specialists, government, national, international organizations, and ministries of health. Her dissertation on more than 3400 myocardial infarction patients was used as a reference by the Food and Drug Administration (FDA) to approve the long-term use of oral anticoagulant therapy in patients who had survived a myocardial infarction. Her research was worldwide used as a reference to define the optimal intensity of oral anticoagulants in post-myocardial infarction patients. She was also a contributor to the FDA report for the approval of coronary stenting for selective placement in selected patients to prevent restenosis after angioplasty. The results were a milestone in interventional cardiology.

Dr. Azar is fluent in four languages (written and spoken): Arabic, English, Dutch, and French.